IRCT2013092414746N1

Trial name or title	The effect of MJ1 (topical dairy extract) versus routine care for treatment of cutaneous leishmaniasis (rural) in Isfahan Iran:a randomised controlled clinical trial (RCTs)
Methods	Randomised controlled trial
Participants	Inclusion criteria: cutaneous leishmaniasis of parasitology confirmed that they have not been previously treated; any other medical problem (such as heart disease, renal, hepatic, or haematological); available for follow‐up; informed consent to participate in the study Exclusion criteria: secondary infections, history of allergic reactions
Interventions	Group 1: in this group patients apply MJ1 skin cream 3 times a day, they are trained to use it for a month with a diameter of 3 mm on the rub of the lesion without dressing Group 2: skin cream MJ1 ‐ 3 times a day ‐ for a month
Outcomes	Lesion size, lesion diameters measured Timepoint: 1, 2, 3, 4 and 8 weeks after starting treatment, participants are evaluated. Method of measurement: at each visit, the 2 dimensions are measured and the area calculated
Starting date	December 2013
Contact information	Dr Mohsen Janghorbani Hezar jarib Street, School of Public Health, Isfahan University of Medical Sciences Isfahan Iran, Islamic Republic Of 00983117922774 janghorbani@hlth.mui.ac.ir
Notes	—